Patents by Inventor Judith DEL CAMPO

Judith DEL CAMPO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139300
    Abstract: The invention relates to immunogenic or vaccine compositions and their use in particular in the prevention or treatment of infectious or cancer disorders. More specifically, the immunogenic or vaccine compositions of the present invention comprises a ribonucleic acid (RNA) molecule comprising an open-reading frame encoding a fusion protein, wherein said fusion protein comprises or essentially consists of: (i) a first polypeptide domain comprising either a. an antigen or a fragment thereof comprising at least one epitope of said antigen, b. a peptide moiety comprising a single epitope of an antigen, or c. a plurality of peptide moieties, wherein each peptide moiety comprises an epitope of an antigen and wherein said peptide moieties are fused together, optionally via peptide linker, said first polypeptide domain being fused to (ii) a second polypeptide domain comprising a C4bp-derived oligomerization domain and a positively charged tail.
    Type: Application
    Filed: September 21, 2023
    Publication date: May 2, 2024
    Inventors: Alexandre LE VERT, Judith DEL CAMPO, Fergal HILL, Francesco DORO
  • Patent number: 9963490
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: May 8, 2018
    Assignee: OSIVAX SAS
    Inventors: Judith Del Campo Ascarateil, Fergal Hill
  • Publication number: 20160215032
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Application
    Filed: December 21, 2015
    Publication date: July 28, 2016
    Inventors: Judith Del Campo Ascarateil, Fergal Hill
  • Patent number: 9388225
    Abstract: The present application is related to a modified protein comprising a protein having a coiled coil domain and a peptide having the sequence such as shown in SEQ ID NO 1: ZXBBBBZ that is linked to the coiled coil domain wherein: Z is any amino acid or is absent; X is any amino acid; B is an arginine (R) or a lysine (K). Said modified protein is in particular an antigen or a carrier protein, associated to an antigen. This modified protein has an increased affinity for negatively charged polymers such as nucleic acids or heparin, and shows an increased immunogenicity.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: July 12, 2016
    Assignee: Imaxio
    Inventors: Judith Del Campo Ascarateil, Imene Turki Hani, Fergal Hill
  • Patent number: 9243047
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: January 26, 2016
    Assignee: Imaxio
    Inventors: Judith Del Campo Ascarateil, Fergal Hill
  • Publication number: 20150098958
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Judith DEL CAMPO ASCARATEIL, Fergal HILL
  • Publication number: 20150093406
    Abstract: The present application is related to a modified protein comprising a protein having a coiled coil domain and a peptide having the sequence such as shown in SEQ ID NO 1: ZXBBBBZ that is linked to the coiled coil domain wherein: Z is any amino acid or is absent; X is any amino acid; B is an arginine (R) or a lysine (K). Said modified protein is in particular an antigen or a carrier protein, associated to an antigen. This modified protein has an increased affinity for negatively charged polymers such as nucleic acids or heparin, and shows an increased immunogenicity.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 2, 2015
    Inventors: Judith DEL CAMPO ASCARATEIL, Imene TURKI HANI, Fergal HILL
  • Publication number: 20060134134
    Abstract: The present invention has applications in the field of immunology, specifically in the sphere of adjuvants and vaccines. The invention aims at obtaining cochlear structures from vesicles found in the outer membranes of microorganisms, in order to employ them in the preparation of adjuvants and vaccines. The invention also discloses a method for obtaining cochlear structures.
    Type: Application
    Filed: November 27, 2003
    Publication date: June 22, 2006
    Inventors: Oliver Perez Martin, Gustavo Bracho Granado, Miriam Lastre Gonzalez, Victoriano Sierra Gozalez, Concepcion Campa Huergo, Nestor Mora Gonzalez, Ramon Barbera Morales, Judith Del Campo Alonso, Tamara Rodriguez Ramirez, Caridad Zayas Vignier, Danay Gil Martinez, Carlos Taboada Suarez
  • Publication number: 20060110435
    Abstract: The present invention relates to the field of Immunology, specifically with the branch of Immuno-Allergy and in particular with the use of adjuvant or carrier compounds, capable of modulating the immune response to allergens. The technical objective that is pursued is to obtain a pharmaceutical preparation of therapeutic or prophylactic use using bacterial proteoliposomes, which transform the allergic response Th2 and IgE when being applied in allergic individuals, toward a protector response Th1; as well as it is able to prevent the appearance and the development of allergies in individuals non-allergic yet. The vaccine composition consists of proteoliposomes derived from Gram-negative bacteria coupled to allergens and optionally contains other adjuvants or antigens. The method for its preparation and an immunization scheme of two doses are provided.
    Type: Application
    Filed: May 8, 2003
    Publication date: May 25, 2006
    Inventors: Miriam de San Juan Bosco Lastre Gonzalez, Oliver Perez Martin, Alexis Labrada Rosado, Igor Bidot Martinez, Gustavo Bracho Granado, Judith Del Campo Alonso, Dainerys Perez Lastre, Elisa Facenda Ramos, Caridad Zayas Vignier, Claudio Rodriguez Martinez, Victoriano Sierra Gonzalez, Jorge Perez Lastre